Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07300956 · ClinicalTrials.gov registry record · Phase 4
Treating Young Children With Attention Deficit Hyperactivity Disorder
A Phase 4 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Not yet
- Registry status
- Phase 4
- Development phase
- 370
- Enrollment target
NCT07300956 is a Phase 4 study that has not yet begun recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 370 participants.
The verdict
NCT07300956, a Phase 4 study, has not yet begun recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 370 participants
- Enrollment target
Study Summary
This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 3 through 5 years (inclusive), as measured by clinician rating of global improvement.
Interventions
- DRUG Methylphenidate (MPH)
- DRUG Guanfacine (GUA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2026-02 |
| Est. Completion | 2030-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07300956
The ClinicalTrials.gov registry entry for NCT07300956 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylphenidate (MPH) is the first listed.
NCT07300956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07300956 about?
NCT07300956 is a clinical study titled "Treating Young Children With Attention Deficit Hyperactivity Disorder". This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 3 through 5 years (inclusive), as measured by clinician rating of global improvement.
What is the current status of trial NCT07300956?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 370 participants. The study started on 2026-02. Estimated completion is 2030-07.
What interventions are being tested in trial NCT07300956?
The interventions under investigation include: Methylphenidate (MPH) (DRUG), Guanfacine (GUA) (DRUG).
Who is sponsoring clinical trial NCT07300956?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.